FMP
Beyond Air, Inc.
XAIR
NASDAQ
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
0.403 USD
-0.013 (-3.23%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Steven Adam Lisi
sector
Healthcare
industry
Medical - Devices
website
https://www.beyondair.netexchange
NASDAQ
Description
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden...
CIK
0001641631
ISIN
US08862L1035
CUSIP
08862L103
Address
900 Stewart Avenue
Phone
516 665 8200
Country
US
Employee
107
IPO Date
Jun 12, 2018
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
XAIR Financial Summary
CIK
0001641631
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
08862L103
ISIN
US08862L1035
Country
US
Price
0.4
Beta
-0.18
Volume Avg.
758.8k
Market Cap
29.1M
Shares
-
52-Week
0.296-2.36
DCF
-0.24
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.29
P/B
-
Website
https://www.beyondair.net
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest XAIR News
It looks like there's no news available.
